Mauna Kea Technologies SAS (ALMKT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.077x

Based on the latest financial reports, Mauna Kea Technologies SAS (ALMKT) has a cash flow conversion efficiency ratio of 0.077x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.28 Million ≈ $-2.67 Million USD) by net assets (€-29.42 Million ≈ $-34.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Mauna Kea Technologies SAS to measure how many days the company can operate on defensive assets alone.

Mauna Kea Technologies SAS - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Mauna Kea Technologies SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mauna Kea Technologies SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mauna Kea Technologies SAS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cayman Tung Ling Co Ltd TWO:2924	-0.055x
Aligos Therapeutics Inc NASDAQ:ALGS	-0.728x
Daechang Steel Co Ltd KQ:140520	-0.048x
Ntaw Holdings Ltd AU:NTD	0.021x
Hotel Fitra International Tbk PT JK:FITT	-0.096x
Seni Jaya Corporation Bhd KLSE:9431	0.128x
Bumi Benowo Sukses Sejahtera Pt JK:BBSS	-0.003x
Progressive Planet Solutions Inc V:PLAN	0.088x

Annual Cash Flow Conversion Efficiency for Mauna Kea Technologies SAS (2010–2024)

The table below shows the annual cash flow conversion efficiency of Mauna Kea Technologies SAS from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Mauna Kea Technologies SAS (ALMKT) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-24.39 Million ≈ $-28.51 Million	€-6.32 Million ≈ $-7.39 Million	0.259x	+494.90%
2023-12-31	€-17.28 Million ≈ $-20.20 Million	€-753.00K ≈ $-880.34K	0.044x	-90.16%
2022-12-31	€-19.93 Million ≈ $-23.29 Million	€-8.83 Million ≈ $-10.32 Million	0.443x	-55.43%
2021-12-31	€-10.33 Million ≈ $-12.08 Million	€-10.27 Million ≈ $-12.01 Million	0.994x	+50.29%
2020-12-31	€-12.08 Million ≈ $-14.12 Million	€-7.99 Million ≈ $-9.34 Million	0.662x	+101.63%
2019-12-31	€253.00K ≈ $295.78K	€-10.27 Million ≈ $-12.01 Million	-40.601x	-2872.05%
2018-12-31	€7.98 Million ≈ $9.33 Million	€-10.90 Million ≈ $-12.74 Million	-1.366x	-134.80%
2017-12-31	€16.74 Million ≈ $19.58 Million	€-9.74 Million ≈ $-11.39 Million	-0.582x	+17.16%
2016-12-31	€11.16 Million ≈ $13.04 Million	€-7.84 Million ≈ $-9.16 Million	-0.702x	+15.62%
2015-12-31	€14.09 Million ≈ $16.47 Million	€-11.73 Million ≈ $-13.71 Million	-0.832x	-18.67%
2014-12-31	€18.15 Million ≈ $21.22 Million	€-12.73 Million ≈ $-14.88 Million	-0.701x	-120.08%
2013-12-31	€30.16 Million ≈ $35.26 Million	€-9.61 Million ≈ $-11.24 Million	-0.319x	+3.61%
2012-12-31	€40.16 Million ≈ $46.95 Million	€-13.28 Million ≈ $-15.53 Million	-0.331x	-176.02%
2011-12-31	€51.57 Million ≈ $60.30 Million	€-6.18 Million ≈ $-7.22 Million	-0.120x	+67.12%
2010-12-31	€6.86 Million ≈ $8.02 Million	€-2.50 Million ≈ $-2.92 Million	-0.364x	--

About Mauna Kea Technologies SAS

PA:ALMKT France Medical Devices

Market Cap

$34.50 Million

€29.51 Million EUR

Market Cap Rank

#23983 Global

#383 in France

Share Price

€0.15

Change (1 day)

-1.54%

52-Week Range

€0.07 - €0.22

All Time High

€5.37